BASF Terminates Acquisition Plan, Evonik Shares Plummet
Evonik rejected two acquisition offers from the German chemical giant BASF
BASF stated that the decision was made due to Evonik's rejection of two acquisition offers.
Summary
After Evonik rejected two acquisition offers, BASF abandoned its plan to acquire Evonik Industries.
The German chemical giant BASF announced that it has abandoned its plan to acquire Evonik Industries. The deal was originally expected to exceed $12 billion; following the news, the share price of Evonik, the target company, plummeted.
BASF stated that the company decided to withdraw from the transaction because Evonik rejected two acquisition bids. With this, BASF's attempt to acquire this smaller domestic competitor has come to an end. BASF had hoped that this acquisition would allow it to better compete with chemical companies in Asia and the Middle East.
In afternoon trading in Europe, Evonik's share price fell by 17%, closing at €18.14, returning to levels seen before BASF's acquisition intentions were revealed in September. BASF's share price rose slightly.
BASF stated in a statement: "Although we indicated that we could consider a modest further increase in the acquisition offer, to date, Evonik's executive board has not shown a willingness for substantive negotiations."
BASF also stated that after assessing Evonik's independent development prospects and potential risks, the company does not warrant a higher valuation. "Based on this judgment, BASF believes that continuing to raise the offer to advance this transaction is not in the best interests of our shareholders."
Evonik did not respond immediately to requests for comment. The company stated last month that it would focus on implementing its independent development strategy and therefore decided not to enter formal negotiations; however, executives were willing to communicate their position with BASF only under strict confidentiality during information exchanges.
In response, BASF expressed surprise at Evonik's executive board's unwillingness to negotiate on the acquisition offer. According to equity data provided by FactSet, the acquisition offer at that time was priced at €24 per share, valuing Evonik at €11.18 billion (approximately $12.27 billion).
The two companies first disclosed their negotiations to the public in September, which drove Evonik's share price higher at that time.
BASF CEO Markus Kamiess stated last month that building a strong German chemical industry is the right way to respond to global competition. He mentioned that amid the overall pressure on the chemical industry, competitors in Asia and the Middle East are making continuous progress.
Kamiess promised to respect Evonik's existing labor agreements and committed not to enforce layoffs before 2032. He added that if integrated into a larger group, Evonik would be able to obtain raw materials at lower costs and more stability, while also enjoying synergies in procurement, infrastructure, research and development, and other areas.
-- Price
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
You may also like

Is Tilray a Buy at Its Record Low, or Is It a Value Trap?

Trump Collaborates with Democrats to Push for Credit Card Interest Rate Cap at 10%

44 State Attorneys General Oppose CFTC Classifying Sports and Election Event Contracts as Swaps

US Treasury sells $15 billion in first nine-day cash bill auction since 2008

EU Leaders Propose Cuts to 2028-2034 Budget and Digital Tax

Cryptocurrency Market Plummets, Bitcoin Falls Below $56,000

Greg Abel Just Approved a Record $9.6 Billion in Stock Buybacks for Berkshire Hathaway Last Quarter, More Than Double the Pace Set in the Second Quarter. Is Berkshire Still a Buy as Shares Sit Near All-Time Highs?

Port Security Personnel at Los Angeles Reach Temporary Agreement to Avert Strike Threat

Hong Kong bill proposes jail for fake crypto license claims

BitcoinHabebe Analyzes Bitcoin Market Trends

Variational’s $1.5 billion trading business has a catch even profitable traders cannot escape

LD Capital founder advises against dip buying before U.S. market stabilizes

Moody's Forecasts 2.3% U.S. GDP Growth in 2026

Fluidkey’s $1.6 million hack exposes a security risk even when private keys never leave users’ devices

CFTC Dropped $TRUMP Probe Due to Leadership Approval Issues

CrowdStrike's Acquisition of Zscaler Could Become One of the Largest Deals in Cybersecurity Industry

Take-Two Interactive vs. Anthropic: Which Market-Moving Stock Is the Better Buy?

Securitize pays its first tokenized Apple stock dividend in USDC

Bitcoin Turns 18: Only 1.5% of the Cryptocurrency is Actively Used and It is Shaping Up as a Credit Source

SBF’s 'The Altruists' Plot Twist: FTX’s Anthropic Shares Would Be Worth $43 Billion

Nearly two-thirds of Square Bitcoin payments were under $20

Bitcoin faces a new inflation threat as a regional US factory price hits a 4 year high

If I Could Only Own 1 Trillion-Dollar Artificial Intelligence (AI) Stock Through 2030, It Would Be Anthropic, Nvidia, or Alphabet. Here's My Top Pick.

JPMorgan Faces £120 Million Bank Tax in the UK, CEO Says Will Seek to Hedge

Warren Buffett Likely to Avoid Nike Stock Amid 79% Decline

Former GM CEO Discusses Mary Barra's Succession Plan: 'It Will Be a Tough Task'

Representative Horsford Seeks House Vote on Cryptocurrency Tax Bill

Would Warren Buffett Buy Anthropic? This Is the One Question He'd Have

Prediction: Nvidia Will Hit a New All-Time High in 2027 (Hint: Watch This Metric)







